Skip to main content

Advertisement

Log in

Structural Valve Deterioration Is Linked to Increased Immune Infiltrate and Chemokine Expression

  • Original Article
  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

We aim to investigate whether structural valve deterioration (SVD) of bioprosthetic xenogenic tissue heart valves (XTHVs) is associated with increased immune cell infiltration and whether co-expression of several chemokines correlates with this increase in immune infiltrate. Explanted XTHVs from patients undergoing redo valve replacement for SVD were obtained. Immunohistochemical, microscopic, and gene expression analysis approaches were used. XTHVs (n = 37) were obtained from 32 patients (mean 67.7 years) after a mean time of 11.6 years post-implantation. Significantly increased immune cellular infiltration was observed in the explanted SVD valves for all immune cell types examined, including T cells, macrophages, B cells, neutrophils, and plasma cells, compared to non-SVD controls. Furthermore, a significantly increased chemokine gradient in explanted SVD valves accompanied immune cell infiltration. These data suggest the development of SVD is associated with a significantly increased burden of immune cellular infiltrate correlated to the induction of a chemokine gradient around the XHTV, representing chronic immune rejection.

Graphical abstract

Proposed interaction between innate and adaptive immunity leading to the development of structural valve deterioration in xenogenic tissue heart valves.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

FFPE:

Formalin-fixed, paraffin-embedded

H&E:

Hematoxylin and eosin

HPF:

High-powered field

RNA:

Ribonucleic acid

SVD:

Structural valve deterioration

VHD:

Valvular heart disease

XTHV:

Xenogenic tissue heart valve

References

  1. Iung, B., & Vahanian, A. (2011). Epidemiology of valvular heart disease in the adult. Nature Reviews. Cardiology, 8, 162–172.

    Article  Google Scholar 

  2. Iung, B., Baron, G., Butchart, E. G., et al. (2003). A prospective survey of patients with valvular heart disease in europe: the Euro Heart Survey on Valvular Heart Disease. European Heart Journal, 24, 1231–1243.

    Article  Google Scholar 

  3. Kaneko T, Aranki S, Javed Q, et al. Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old. Journal of Thoracic and Cardiovascular Surgery, 147, 117–126.

  4. Johnston, D. R., Soltesz, E. G., Vakil, N., et al. (2015). Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. The Annals of Thoracic Surgery, 99, 1239–1247.

    Article  Google Scholar 

  5. Dvir, D., Bourguignon, T., Otto, C. M., et al. (2018). Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves. Circulation, 137, 388–399.

    Article  Google Scholar 

  6. Manji, R. A., Hara, H., & Cooper, D. K. C. (2015). Characterization of the cellular infiltrate in bioprosthetic heart valves explanted from patients with structural valve deterioration. Xenotransplantation, 22, 406–407.

    Article  Google Scholar 

  7. Manji, R. A., Lee, W., & Cooper, D. K. C. (2015). Xenograft bioprosthetic heart valves: past, present and future. International Journal of Surgery, 23, 280–284.

    Article  Google Scholar 

  8. O’Keefe, K. L., Cohle, S. D., McNamara, J. E., & Hooker, R. L. (2011). Early catastrophic stentless valve failure secondary to possible immune reaction. The Annals of Thoracic Surgery, 91, 1269–1272.

    Article  Google Scholar 

  9. Dignan, R., O’Brien, M., Hogan, P., et al. (2003). Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens. The Journal of Heart Valve Disease, 12, 382–391.

    PubMed  Google Scholar 

  10. Human, P., & Zilla, P. (2001). Inflammatory and immune processes: the neglected villain of bioprosthetic degeneration? Journal of Long-Term Effects of Medical Implants, 11, 199–220.

    Article  CAS  Google Scholar 

  11. Chen, R. H., Kadner, A., Mitchell, R. N., & Adams, D. H. (2000). Fresh porcine cardiac valves are not rejected in primates. The Journal of Thoracic and Cardiovascular Surgery, 119, 1216–1220.

    Article  CAS  Google Scholar 

  12. Böer, U., Buettner, F. F. R., Schridde, A., et al. (2017). Antibody formation towards porcine tissue in patients implanted with crosslinked heart valves is directed to antigenic tissue proteins and αGal epitopes and is reduced in healthy vegetarian subjects. Xenotransplantation, 24, e12288.

  13. Bromley, S. K., Peterson, D. A., Gunn, M. D., & Dustin, M. L. (2000). Cutting edge: hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation. Journal of Immunology, 165, 15–19.

    Article  CAS  Google Scholar 

  14. Siddiqui, I., Erreni, M., van Brakel, M., Debets, R., & Allavena, P. (2016). Enhanced recruitment of genetically modified CX3CR1-positive human T cells into fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. Journal for Immunotherapy of Cancer, 4, 21.

    Article  Google Scholar 

  15. Nagarsheth, N., Wicha, M. S., & Zou, W. (2017). Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nature Reviews. Immunology, 17, 559–572.

    Article  CAS  Google Scholar 

  16. Adam, B. A., Smith, R. N., Rosales, I. A., et al. (2017). Chronic antibody-mediated rejection in nonhuman primate renal allografts: validation of human histological and molecular phenotypes. American Journal of Transplantation, 17, 2841–2850.

    Article  CAS  Google Scholar 

  17. Adam, B., Afzali, B., Dominy, K. M., et al. (2016). Multiplexed color-coded probe-based gene expression assessment for clinical molecular diagnostics in formalin-fixed paraffin-embedded human renal allograft tissue. Clinical Transplantation, 30, 295–305.

    Article  CAS  Google Scholar 

  18. Butany, J., Leong, S. W., Cunningham, K. S., D’Cruz, G., Carmichael, K., & Yau, T. M. (2007). A 10-year comparison of explanted Hancock-II and Carpentier-Edwards supraannular bioprostheses. Cardiovascular Pathology, 16, 4–13.

    Article  Google Scholar 

  19. Sellers, S. L., Turner, C. T., Sathananthan, J., et al. (2018). Transcatheter aortic heart valves: histological analysis providing insight to leaflet thickening and structural valve degeneration. JACC: Cardiovascular Imaging, 12, 135–145.

  20. Shetty, R., Pibarot, P., Audet, A., et al. (2009). Lipid-mediated inflammation and degeneration of bioprosthetic heart valves. European Journal of Clinical Investigation, 39, 471–480.

    Article  CAS  Google Scholar 

  21. Palomino, D. C. T., & Marti, L. C. (2015). Chemokines and immunity. Einstein (Sao Paulo), 13, 469–473.

    Article  Google Scholar 

  22. Bozso, S. J., Kang, J. J. H., Al-Adra, D., et al. (2019). Outcomes following bioprosthetic valve replacement in prior non-cardiac transplant recipients. Clinical Transplantation, 33, e13720.

    Article  Google Scholar 

  23. Lund, O., Nielsen, S. L., Arildsen, H., Ilkjaer, L. B., & Pilegaard, H. K. (2000). Standard aortic St. Jude valve at 18 years: performance profile and determinants of outcome. The Annals of Thoracic Surgery, 69, 1459–1465.

    Article  CAS  Google Scholar 

  24. Grunkemeier, G. L., Furnary, A. P., Wu, Y., Wang, L., & Starr, A. (2012). Durability of pericardial versus porcine bioprosthetic heart valves. The Journal of Thoracic and Cardiovascular Surgery, 144, 1381–1386.

    Article  Google Scholar 

  25. Nalluri, N., Atti, V., Munir, A. B., et al. (2018). Valve in valve transcatheter aortic valve implantation (ViV-TAVI) versus redo-surgical aortic valve replacement (redo-SAVR): a systematic review and meta-analysis. Journal of Interventional Cardiology, 31, 661–671.

    Article  Google Scholar 

  26. Kühne, L., Jung, B., Poth, H., et al. (2017). Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy. BMC Immunology, 18, 52.

  27. Girlanda, R., Kleiner, D. E., Duan, Z., et al. (2008). Monocyte infiltration and kidney allograft dysfunction during acute rejection. American Journal of Transplantation, 8, 600.

    Article  CAS  Google Scholar 

  28. Veinot, J. P., Prichett-Pejic, W., Song, J., et al. (2006). CD117-positive cells and mast cells in adult human cardiac valves--observations and implications for the creation of bioengineered grafts. Cardiovascular Pathology, 15, 36–40.

    Article  CAS  Google Scholar 

  29. Kim, W. G., Sung, K., & Seo, J. W. (2007). Time-related histopathologic analyses of immunologically untreated porcine valved conduits implanted in a porcine-to-goat model. Artificial Organs, 31, 105–113.

    Article  Google Scholar 

  30. Ozkan, S., Akay, T. H., Gultekin, B., Sezgin, A., Tokel, K., & Aslamaci, S. (2007). Xenograft transplantation in congenital cardiac surgery at baskent university: midterm results. Transplantation Proceedings, 39, 1250–1254.

    Article  CAS  Google Scholar 

  31. Wood, K. J., & Goto, R. (2012). Mechanisms of rejection: current perspectives. Transplantation, 93, 1–10.

    Article  Google Scholar 

  32. Nguyen, D. C., Joyner, C. J., Sanz, I., & Lee, F. E. (2019). Factors affecting early antibody secreting cell maturation into long-lived plasma cells. Frontiers in Immunology, 10, 2138.

    Article  CAS  Google Scholar 

  33. Naso, F., Gandaglia, A., Iop, L., Spina, M., & Gerosa, G. (2012). Alpha-gal detectors in xenotransplantation research: a word of caution. Xenotransplantation, 19, 215–220.

    Article  Google Scholar 

  34. Galili, U. (2001). The α-gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation. Biochimie, 83, 557–563.

    Article  CAS  Google Scholar 

  35. McMorrow, I. M., Comrack, C. A., Sachs, D. H., & DerSimonian, H. (1997). Heterogeneity of human anti-pig natural antibodies cross-reactive with the gal (alpha1,3) galactose epitope. Transplantation, 64, 501–510.

    Article  CAS  Google Scholar 

Download references

Funding

University Hospital Foundation, Edmonton, AB

Edmonton Civic Employees Charitable Assistance Fund, Edmonton, AB

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeevan Nagendran.

Ethics declarations

Conflict of Interests

The authors declare that they have no conflicts of interest.

Statement of Informed Consent

Patient and procedural data were collected from retrospective chart reviews. The Research Ethics Board at the University of Alberta approved the research protocol, including a waiver of individual consent.

Additional information

Associate Editor Adrian Chester oversaw the review of this article

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bozso, S.J., Kang, J.J., Basu, R. et al. Structural Valve Deterioration Is Linked to Increased Immune Infiltrate and Chemokine Expression. J. of Cardiovasc. Trans. Res. 14, 503–512 (2021). https://doi.org/10.1007/s12265-020-10080-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-020-10080-x

Keywords

Navigation